Notably, many cancer treatment strategies, such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy, highly rely on the activation of IFN-I signaling pathways, especially the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway.3 Here, STING1 is linked to cancer.